Shenzhen Chipscreen Biosciences Co (688321) — Net Asset Quality Index
Shenzhen Chipscreen Biosciences Co (688321) has a Net Asset Quality Index of 45.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.63 Billion minus total liabilities of CN¥1.98 Billion yields net assets of CN¥1.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Shenzhen Chipscreen Biosciences Co liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shenzhen Chipscreen Biosciences Co Net Asset Quality Index Over Time (2016–2024)
This chart shows how Shenzhen Chipscreen Biosciences Co's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 45.6%, representing net assets of CN¥1.66 Billion against total assets of CN¥3.63 Billion CNY. Explore Shenzhen Chipscreen Biosciences Co cash conversion from operations to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Shenzhen Chipscreen Biosciences Co (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Shenzhen Chipscreen Biosciences Co from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Shenzhen Chipscreen Biosciences Co market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 48.6% | CN¥1.58 Billion | CN¥3.25 Billion | CN¥1.67 Billion | ▼ -4.7 pp |
| 2023 | 53.4% | CN¥1.71 Billion | CN¥3.20 Billion | CN¥1.49 Billion | ▼ -1.0 pp |
| 2022 | 54.4% | CN¥1.58 Billion | CN¥2.90 Billion | CN¥1.32 Billion | ▼ -20.4 pp |
| 2021 | 74.8% | CN¥1.42 Billion | CN¥1.89 Billion | CN¥476.79 Million | ▼ -11.7 pp |
| 2020 | 86.5% | CN¥1.49 Billion | CN¥1.73 Billion | CN¥232.44 Million | ▲ +1.0 pp |
| 2019 | 85.5% | CN¥1.45 Billion | CN¥1.69 Billion | CN¥245.10 Million | ▲ +18.9 pp |
| 2018 | 66.6% | CN¥476.90 Million | CN¥716.34 Million | CN¥239.44 Million | ▼ -2.1 pp |
| 2017 | 68.7% | CN¥450.55 Million | CN¥656.02 Million | CN¥205.47 Million | ▲ +15.7 pp |
| 2016 | 52.9% | CN¥213.40 Million | CN¥403.13 Million | CN¥189.73 Million | — |